As an outbreak of Ebola in central Africa continues to worsen, the federal government has tapped a little-known biotech in San Diego to provide doses of an experimental antibody that may be used to treat the deadly virus.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
As an outbreak of Ebola in central Africa continues to worsen, the federal government has tapped a little-known biotech in San Diego to provide doses of an experimental antibody that may be used to treat the deadly virus.